tiprankstipranks
Advertisement
Advertisement

LYPHF Stock Latest News

Luye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015
Company AnnouncementsLuye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015
16d ago
Luye Pharma Advances Alzheimer’s Psychosis Drug LY03017 Into China Phase II Trial
PremiumCompany Announcements
Luye Pharma Advances Alzheimer’s Psychosis Drug LY03017 Into China Phase II Trial
20d ago
Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
PremiumCompany Announcements
Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
27d ago
Luye Pharma Delivers Double-Digit Profit Growth in 2025 but Skips Dividend
PremiumCompany Announcements
Luye Pharma Delivers Double-Digit Profit Growth in 2025 but Skips Dividend
1M ago
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
2M ago
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
PremiumCompany AnnouncementsLuye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
3M ago
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
Premium
Company Announcements
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
3M ago
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
Premium
Company Announcements
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
4M ago
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
PremiumCompany Announcements
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
4M ago
Luye Pharma Outlines Board Line-Up and Committee Structure
PremiumCompany Announcements
Luye Pharma Outlines Board Line-Up and Committee Structure
4M ago
Luye Pharma Tightens Governance With Updated Nomination Committee Mandate
PremiumCompany Announcements
Luye Pharma Tightens Governance With Updated Nomination Committee Mandate
4M ago
Luye Pharma Structures RMB1.09 Billion Nanjing Luye Stake Transfer With Options and Guarantees
PremiumCompany Announcements
Luye Pharma Structures RMB1.09 Billion Nanjing Luye Stake Transfer With Options and Guarantees
4M ago
Luye Pharma Grants Nhwa Exclusive China Rights for Three Long-Acting Schizophrenia Drugs
PremiumCompany AnnouncementsLuye Pharma Grants Nhwa Exclusive China Rights for Three Long-Acting Schizophrenia Drugs
4M ago
Luye Pharma Completes Strategic Issuance of Exchangeable Preference Shares
Premium
Company Announcements
Luye Pharma Completes Strategic Issuance of Exchangeable Preference Shares
5M ago
Luye Pharma’s Five New Drugs Gain Inclusion in China’s 2025 Reimbursement Lists
Premium
Company Announcements
Luye Pharma’s Five New Drugs Gain Inclusion in China’s 2025 Reimbursement Lists
5M ago
Luye Pharma Gains FDA Approval for New CNS Drug Trials
PremiumCompany Announcements
Luye Pharma Gains FDA Approval for New CNS Drug Trials
5M ago
Luye Pharma Announces USD150 Million Exchangeable Shares Issuance
PremiumCompany Announcements
Luye Pharma Announces USD150 Million Exchangeable Shares Issuance
6M ago
Luye Pharma’s New Phase 1 Study: A Potential Game-Changer in Neurological Treatments
PremiumCompany Announcements
Luye Pharma’s New Phase 1 Study: A Potential Game-Changer in Neurological Treatments
6M ago
LYPHF
Luye Pharma’s New Trial on Tardive Dyskinesia: A Potential Game Changer?
PremiumCompany Announcements
Luye Pharma’s New Trial on Tardive Dyskinesia: A Potential Game Changer?
6M ago
LYPHF
Luye Pharma’s New Study on LY03017: A Potential Game-Changer in Neuropsychiatric Treatment
PremiumCompany AnnouncementsLuye Pharma’s New Study on LY03017: A Potential Game-Changer in Neuropsychiatric Treatment
6M ago
LYPHF
Luye Pharma’s Promising Phase III Trial for Relapsed SCLC: A Potential Game-Changer
Premium
Company Announcements
Luye Pharma’s Promising Phase III Trial for Relapsed SCLC: A Potential Game-Changer
6M ago
LYPHF
Luye Pharma Converts Convertible Bonds to Shares
Premium
Company Announcements
Luye Pharma Converts Convertible Bonds to Shares
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >